← Alle mensen

TA

Timur Andabekov

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monothera...
European journal of cancer (Oxford, England : 1990) · 9 september 2025
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positi...
The Lancet. Oncology · 2024-11